200
Participants
Start Date
August 31, 2015
Primary Completion Date
September 30, 2016
Study Completion Date
September 30, 2016
Paracetamol
1000 mg of paracetamol (perfalgan 10mg/ml solutionBristol-Myers Squibb\_UK) intravenous (IV) was given 100patients
Dexketoprofen
Second group: dexketoprofen 50 MG (Arveles ampoule -Ufsa- Istanbul) intravenous (IV) was given 100 patients
Pamukkale University, Denizli
Pamukkale University
OTHER